• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种介导衰老癌细胞免疫破坏的抗生素。

An antibiotic that mediates immune destruction of senescent cancer cells.

作者信息

Casagrande Raffi Gabriele, Chen Jian, Feng Xuezhao, Chen Zhen, Lieftink Cor, Deng Shuang, Mo Jinzhe, Zeng Chuting, Steur Marit, Wang Jing, Bleijerveld Onno B, Hoekman Liesbeth, van der Wel Nicole, Wang Feng, Beijersbergen Roderick, Zheng Jian, Bernards Rene, Wang Liqin

机构信息

Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands.

State Key Laboratory of Oncology in South China, Department of Experimental Research, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.

出版信息

Proc Natl Acad Sci U S A. 2024 Dec 24;121(52):e2417724121. doi: 10.1073/pnas.2417724121. Epub 2024 Dec 18.

DOI:10.1073/pnas.2417724121
PMID:39693343
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11670111/
Abstract

Drugs that eliminate senescent cells, senolytics, can be powerful when combined with prosenescence cancer therapies. Using a CRISPR/Cas9-based genetic screen, we identify here SLC25A23 as a vulnerability of senescent cancer cells. Suppressing SLC25A23 disrupts cellular calcium homeostasis, impairs oxidative phosphorylation, and interferes with redox signaling, leading to death of senescent cells. These effects can be replicated by salinomycin, a cation ionophore antibiotic. Salinomycin prompts a pyroptosis-apoptosis-necroptosis (PAN)optosis-like cell death in senescent cells, including apoptosis and two forms of immunogenic cell death: necroptosis and pyroptosis. Notably, we observed that salinomycin treatment or SLC25A23 suppression elevates reactive oxygen species, upregulating death receptor 5 via Jun N-terminal protein kinase (JNK) pathway activation. We show that a combination of a death receptor 5 (DR5) agonistic antibody and salinomycin is a robust senolytic cocktail. We provide evidence that this drug combination provokes a potent natural killer (NK) and CD8+ T cell-mediated immune destruction of senescent cancer cells, mediated by the pyroptotic cytokine interleukin 18 (IL18).

摘要

清除衰老细胞的药物(衰老细胞溶解剂)与促衰老癌症疗法联合使用时可能会产生强大效果。通过基于CRISPR/Cas9的基因筛选,我们在此确定SLC25A23是衰老癌细胞的一个脆弱靶点。抑制SLC25A23会破坏细胞钙稳态,损害氧化磷酸化,并干扰氧化还原信号传导,导致衰老细胞死亡。这些效应可被盐霉素(一种阳离子离子载体抗生素)复制。盐霉素促使衰老细胞发生一种类似于焦亡-凋亡-坏死性凋亡(PAN)的细胞死亡,包括凋亡以及两种形式的免疫原性细胞死亡:坏死性凋亡和焦亡。值得注意的是,我们观察到盐霉素处理或SLC25A23抑制会升高活性氧水平,通过激活Jun N端蛋白激酶(JNK)途径上调死亡受体5。我们表明,死亡受体5(DR5)激动性抗体与盐霉素的组合是一种强大的衰老细胞溶解鸡尾酒疗法。我们提供的证据表明,这种药物组合会引发由焦亡细胞因子白细胞介素18(IL18)介导的强大的自然杀伤(NK)细胞和CD8 + T细胞介导的衰老癌细胞免疫破坏。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bac8/11670111/3966f8cbc16f/pnas.2417724121fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bac8/11670111/408d205ffe7c/pnas.2417724121fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bac8/11670111/23b760a3829b/pnas.2417724121fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bac8/11670111/301a0cea3346/pnas.2417724121fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bac8/11670111/dc0450bf307b/pnas.2417724121fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bac8/11670111/3966f8cbc16f/pnas.2417724121fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bac8/11670111/408d205ffe7c/pnas.2417724121fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bac8/11670111/23b760a3829b/pnas.2417724121fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bac8/11670111/301a0cea3346/pnas.2417724121fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bac8/11670111/dc0450bf307b/pnas.2417724121fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bac8/11670111/3966f8cbc16f/pnas.2417724121fig05.jpg

相似文献

1
An antibiotic that mediates immune destruction of senescent cancer cells.一种介导衰老癌细胞免疫破坏的抗生素。
Proc Natl Acad Sci U S A. 2024 Dec 24;121(52):e2417724121. doi: 10.1073/pnas.2417724121. Epub 2024 Dec 18.
2
Identification of a senescence-associated transcriptional program in skeletal muscle of cachectic pancreatic-tumor-bearing mice.在携带胰腺肿瘤的恶病质小鼠骨骼肌中鉴定衰老相关转录程序。
Am J Physiol Cell Physiol. 2025 Apr 1;328(4):C1125-C1134. doi: 10.1152/ajpcell.00816.2024. Epub 2025 Feb 24.
3
Interventions for fertility preservation in women with cancer undergoing chemotherapy.对接受化疗的癌症女性进行生育力保存的干预措施。
Cochrane Database Syst Rev. 2025 Jun 19;6:CD012891. doi: 10.1002/14651858.CD012891.pub2.
4
Repurposing MDM2 inhibitor RG7388 for TP53-mutant NSCLC: a p53-independent pyroptotic mechanism via ROS/p-p38/NOXA/caspase-3/GSDME axis.将MDM2抑制剂RG7388重新用于治疗TP53突变的非小细胞肺癌:通过ROS/p-p38/NOXA/半胱天冬酶-3/GSDME轴的一种不依赖p53的细胞焦亡机制。
Cell Death Dis. 2025 Jun 17;16(1):452. doi: 10.1038/s41419-025-07770-2.
5
Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians.评估慢性阻塞性肺疾病干预措施的比较效果:面向临床医生的网状Meta分析教程
Respir Res. 2024 Dec 21;25(1):438. doi: 10.1186/s12931-024-03056-x.
6
Prehabilitation during neoadjuvant chemotherapy results in an enhanced immune response in esophageal adenocarcinoma tumors: A randomized controlled trial.新辅助化疗期间的术前康复训练可增强食管腺癌肿瘤的免疫反应:一项随机对照试验。
J Sport Health Sci. 2025 Jun 3:101063. doi: 10.1016/j.jshs.2025.101063.
7
Biologically targeted dual adaptive and innate nano-Immunotherapy for clear cell renal cell carcinoma treatment.用于透明细胞肾细胞癌治疗的生物靶向双重适应性和先天性纳米免疫疗法。
Mol Cancer. 2025 Jun 18;24(1):181. doi: 10.1186/s12943-025-02382-y.
8
Evaluating the predictive power of combined gene expression dynamics from single cells on antibiotic survival.评估来自单细胞的联合基因表达动态对抗生素存活的预测能力。
mSystems. 2025 Jun 17;10(6):e0158824. doi: 10.1128/msystems.01588-24. Epub 2025 May 20.
9
Prediction, screening and characterization of novel bioactive tetrapeptide matrikines for skin rejuvenation.预测、筛选和鉴定具有皮肤年轻化功效的新型生物活性四肽基质。
Br J Dermatol. 2024 Jun 20;191(1):92-106. doi: 10.1093/bjd/ljae061.
10
Role of interleukin-16 in human diseases: a novel potential therapeutic target.白细胞介素-16在人类疾病中的作用:一个新的潜在治疗靶点。
Front Immunol. 2025 Jun 2;16:1524026. doi: 10.3389/fimmu.2025.1524026. eCollection 2025.

引用本文的文献

1
Cellular senescence in cancer: from mechanism paradoxes to precision therapeutics.癌症中的细胞衰老:从机制悖论到精准治疗
Mol Cancer. 2025 Aug 8;24(1):213. doi: 10.1186/s12943-025-02419-2.
2
Advances in the study of death receptor 5.死亡受体5的研究进展
Front Pharmacol. 2025 Mar 12;16:1549808. doi: 10.3389/fphar.2025.1549808. eCollection 2025.

本文引用的文献

1
Dasabuvir alleviates 5-fluorouracil-induced intestinal injury through anti-senescence and anti-inflammatory.达沙布韦通过抗衰老和抗炎缓解 5-氟尿嘧啶诱导的肠道损伤。
Sci Rep. 2024 Jul 8;14(1):15730. doi: 10.1038/s41598-024-66771-x.
2
Cell death.细胞死亡。
Cell. 2024 Jan 18;187(2):235-256. doi: 10.1016/j.cell.2023.11.044.
3
Tumor senescence leads to poor survival and therapeutic resistance in human breast cancer.肿瘤衰老导致人类乳腺癌患者生存率低下和产生治疗抗性。
Front Oncol. 2023 Mar 2;13:1097513. doi: 10.3389/fonc.2023.1097513. eCollection 2023.
4
Effect of long-term antihypertensive treatment on cerebrovascular structure and function in hypertensive rats.长期降压治疗对高血压大鼠脑血管结构和功能的影响。
Sci Rep. 2023 Mar 1;13(1):3481. doi: 10.1038/s41598-023-30515-0.
5
Regulation and role of calcium in cellular senescence.钙在细胞衰老中的调节和作用。
Cell Calcium. 2023 Mar;110:102701. doi: 10.1016/j.ceca.2023.102701. Epub 2023 Jan 27.
6
cFLIP suppression and DR5 activation sensitize senescent cancer cells to senolysis.cFLIP抑制和DR5激活使衰老癌细胞对衰老细胞溶解敏感。
Nat Cancer. 2022 Nov;3(11):1284-1299. doi: 10.1038/s43018-022-00462-2. Epub 2022 Nov 22.
7
Metformin ameliorates 5-fluorouracil-induced intestinalinjury by inhibiting cellular senescence, inflammation, and oxidative stress.二甲双胍通过抑制细胞衰老、炎症和氧化应激来改善5-氟尿嘧啶诱导的肠道损伤。
Int Immunopharmacol. 2022 Dec;113(Pt A):109342. doi: 10.1016/j.intimp.2022.109342. Epub 2022 Oct 27.
8
Prognostic implications of cellular senescence in resected non-small cell lung cancer.细胞衰老对切除的非小细胞肺癌的预后影响
Transl Lung Cancer Res. 2022 Aug;11(8):1526-1539. doi: 10.21037/tlcr-22-192.
9
Senescence and cancer - role and therapeutic opportunities.衰老与癌症——作用与治疗机遇。
Nat Rev Clin Oncol. 2022 Oct;19(10):619-636. doi: 10.1038/s41571-022-00668-4. Epub 2022 Aug 31.
10
Myosin 1D and the branched actin network control the condensation of p62 bodies.肌球蛋白 1D 和分支的肌动蛋白网络控制 p62 体的凝聚。
Cell Res. 2022 Jul;32(7):659-669. doi: 10.1038/s41422-022-00662-6. Epub 2022 Apr 27.